Verano (VRNOF) Stock Price, News & Analysis

Company Overview

Verano Holdings Corp. is a U.S. cannabis company that cultivates, processes, distributes and sells cannabis products in state-regulated markets. The company operates a vertically integrated business model, combining cultivation and manufacturing operations with retail dispensaries.

Verano markets products under brands including Verano, Savvy and Encore, as well as the MÜV brand acquired through its purchase of AltMed. Its product portfolio includes flower, pre-rolls, concentrates, edibles, tinctures and other cannabis products, depending on the regulations in each market.

Founded in 2014 and headquartered in Chicago, Verano serves adult-use and medical cannabis consumers across multiple U.S. states, including markets such as Illinois, Florida, Pennsylvania, New Jersey, Maryland, Ohio, Arizona, Nevada, Massachusetts and Michigan. The company’s operations are conducted through state-licensed businesses, as cannabis remains subject to differing state regulations in the United States.

Verano was founded by George Archos, who has served as the company’s chief executive officer. The company became publicly traded in Canada in 2021 and is also quoted in the United States under the symbol VRNOF.

Key Stats

• Today's Range: $1.26 to $1.26
• 50-Day Range: $1.26 to $1.26
• 52-Week Range: $0.41 to $3.58
• Volume: N/A
• Average Volume: 476,705 shs
• Market Capitalization: $455.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Verano Stock Analysis - MarketRank™

Verano scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Verano has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Verano has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Verano are expected to grow in the coming year, from ($0.18) to ($0.13) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Verano is -1.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Verano is -1.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Verano has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for VRNOF.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Verano does not currently pay a dividend.

Dividend Growth

Verano does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

2 people have searched for VRNOF on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Verano insiders have not sold or bought any company stock.

Percentage Held by Insiders

9.10% of the stock of Verano is held by insiders.

Percentage Held by Institutions

8.98% of the stock of Verano is held by institutions.

Company Calendar

• Last Earnings: 10/29/2025
• Today: 10/08/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VRNOF
• Previous Symbol: OTC:VRNOF
• CIK: 1848416
• Web: www.verano.com
• Phone: 312-265-0730
• Fax: N/A
• Employees: 3,890
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$341.86 million
• Net Margins: -41.68%
• Pretax Margin: -37.43%
• Return on Equity: -9.54%
• Return on Assets: -4.51%

Debt

• Debt-to-Equity Ratio: 0.56
• Current Ratio: 2.69
• Quick Ratio: 1.16

Sales & Book Value

• Annual Sales: $878.59 million
• Price / Sales: 0.52
• Cash Flow: $0.19 per share
• Price / Cash Flow: 6.66
• Book Value: $2.44 per share
• Price / Book: 0.52

Miscellaneous

• Outstanding Shares: 361,816,000
• Free Float: 328,891,000
• Market Cap: $455.89 million
• Optionable: Not Optionable
• Beta: 0.87